Stocks Hitting 52-Week Lows

By: via Benzinga
Celladon Corp (NASDAQ: CLDN) shares fell 79.02 percent to reach a new 52-week low of $2.87 on the failed CUPID2 trial of MYDICAR in ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.